Physician profile
Manish Patel
NPI 1912147927
$1,004.80
in general payments reported to CMS, 2019-2025
12 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $12.98 · 2022: $151 · 2024: $564 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $511 · Food and Beverage: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $510.90 |
| Food and Beverage | $227.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $563.66 | 2024 | Inspire |
| Harmony Biosciences LLC | $94.99 | 2022 | |
| Intuitive Surgical, INC. | $76.92 | 2025 | |
| Pulmonx Corporation | $62.73 | 2025 | Pulmonx Chartis Tablet Console, Chartis Catheter, Zephyr Endobronchial Valve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.42 | 2019-2022 | |
| Pfizer INC. | $47.93 | 2020-2025 | |
| Glaxosmithkline, LLC. | $26.07 | 2019 | |
| Shire North American Group INC | $22.37 | 2019 | |
| Abbvie INC. | $16.89 | 2022 | |
| Allergan, INC. | $13.33 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.66 | 2019 | |
| Merck Sharp & Dohme LLC | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manish Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.